AI ultrasound company See-Mode Technologies has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its thyroid ultrasound analysis and reporting software.
The software helps reduce reporting time and mitigates operator experience variations for thyroid ultrasound, the company said. It detects nodules in single or multinodular thyroid ultrasound images and automatically classifies each according to the American College of Radiology’s (ACR) TI-RADS rating system, according to the firm.
